Ocuvir Eye Ointment contains Acyclovir 3% w/w, an antiviral agent indicated for the treatment of herpetic keratitis and other ocular infections caused by herpes simplex virus. Acyclovir acts by inhibiting viral DNA polymerase, thereby preventing viral replication and reducing the severity and duration of the infection. This ointment is specifically formulated for ophthalmic use, providing targeted delivery to the affected area, which enhances therapeutic efficacy while minimizing systemic absorption and associated side effects. Ocuvir Eye Ointment is recommended for patients presenting with epithelial keratitis, dendritic ulcers, and other superficial ocular herpes infections. The ointment should be applied as directed by a healthcare professional, typically five times daily at regular intervals until clinical resolution is observed. Care must be taken to avoid contamination of the applicator tip to prevent secondary infections. Patients should be advised to report any signs of hypersensitivity or worsening symptoms promptly. Use during pregnancy and lactation should be considered only if the potential benefit justifies the potential risk to the fetus or infant. Ocuvir Eye Ointment is contraindicated in individuals with known hypersensitivity to acyclovir or any component of the formulation. Proper storage conditions include keeping the ointment in a cool, dry place away from direct light.